Cyrano Therapeutics, Inc. — Form D
Cyrano Therapeutics, Inc. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-16. The offering totals $12.8M, of which $4.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-11-16
- Form: D
- Accession: 0001832334-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.8M
- Amount sold: $4.1M
- Remaining: $8.7M
- Investors: 11
- Date of first sale: 2020-11-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380646
Issuer
- Name: Cyrano Therapeutics, Inc.
- CIK: 0001832334
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5125 MACARTHUR BLVD. NW, #20, WASHINGTON, DC, 20016
- Phone: 1 (925) 822-6461
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Gerry Brunk | Director | Ann Arbor, MI |
| Richard Geoffrion | Director | AMERICAN CANYON, CA |
| Robert Henkin | Director | Washington, DC |
| Takahide Koda | Director | Irvine, CA |
| Richard Geoffrion | Executive Officer | AMERICAN CANYON, CA |
More